The July 10, 2013, article by Baselga et al entitled “Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer” (J Clin Oncol 31:2586-2592, 2013) was published with an omission.
The Acknowledgements section should have included the sentence: “This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.”
This has been corrected as of December 4, 2017. The authors apologize for the error.